Mark P. Ridgill

727 total citations
13 papers, 487 citations indexed

About

Mark P. Ridgill is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Mark P. Ridgill has authored 13 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 4 papers in Organic Chemistry. Recurrent topics in Mark P. Ridgill's work include Chemical Synthesis and Analysis (4 papers), Neuroscience and Neuropharmacology Research (4 papers) and Receptor Mechanisms and Signaling (4 papers). Mark P. Ridgill is often cited by papers focused on Chemical Synthesis and Analysis (4 papers), Neuroscience and Neuropharmacology Research (4 papers) and Receptor Mechanisms and Signaling (4 papers). Mark P. Ridgill collaborates with scholars based in United Kingdom and United States. Mark P. Ridgill's co-authors include Paul D. Leeson, Janusz J. Kulagowski, Neil R. Curtis, C I Ragan, Frances Emms, Stephen B. Freedman, Smita S. Patel, Shil Patel, Ian M. Mawer and Raymond Baker and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Mark P. Ridgill

13 papers receiving 460 citations

Peers

Countries citing papers authored by Mark P. Ridgill

Since Specialization

Citations

This map shows the geographic impact of Mark P. Ridgill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark P. Ridgill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark P. Ridgill more than expected).

Fields of papers citing papers by Mark P. Ridgill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark P. Ridgill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark P. Ridgill. The network helps show where Mark P. Ridgill may publish in the future.

Co-authorship network of co-authors of Mark P. Ridgill

This figure shows the co-authorship network connecting the top 25 collaborators of Mark P. Ridgill. A scholar is included among the top collaborators of Mark P. Ridgill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark P. Ridgill. Mark P. Ridgill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Regioselective Rapid Analogue Syntheses of 1-Methyl-3,5-diarylpyrazoles via Palladium-catalysed Coupling to 3(5)-Pyrazolyl Nonaflates 2004 ·Synlett ·Ian Collins, (unknown), Mark P. Ridgill	4
2	Regioselective Rapid Analogue Syntheses of 1‐Methyl‐3,5‐diarylpyrazoles via Palladium‐Catalyzed Coupling to 3(5)‐Pyrazolyl Nonaflates. 2004 ·ChemInform ·(unknown), Mark P. Ridgill, Ian Collins	2
3	4,4-Disubstituted cyclohexylamine NK1 receptor antagonists II 2002 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Emma Carlson, José L. Castro, Gary G. Chicchi, (unknown), Jerry Di Salvo, Jason Elliott, Gregory J. Hollingworth, Marc M. Kurtz, Mark P. Ridgill, Wayne Rycroft, Kwei‐Lan Tsao, Christopher J. Swain	16
4	4,4-Disubstituted cyclohexylamine NK1 receptor antagonists I 2002 ·Bioorganic & Medicinal Chemistry Letters ·Jason Elliott, José L. Castro, Gary G. Chicchi, (unknown), (unknown), Gregory J. Hollingworth, Mark P. Ridgill, Wayne Rycroft, Marc M. Kurtz, Duncan Shaw, Christopher J. Swain, Kwei‐Lan Tsao, Lihu Yang	8
5	2-Aryl indole NK1 antagonists: optimisation of the amide substituent 2001 ·Bioorganic & Medicinal Chemistry Letters ·Duncan Shaw, Gary G. Chicchi, Jason Elliott, Marc M. Kurtz, Denise Morrison, Mark P. Ridgill, (unknown), Alan P. Watt, Angela Williams, Christopher J. Swain	10
6	2-Aryl indole NK1 receptor antagonists: optimisation of the 2-Aryl ring and the indole nitrogen substituent 2001 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Gary G. Chicchi, (unknown), Jason Elliott, Gregory J. Hollingworth, Marc M. Kurtz, Mark P. Ridgill, Wayne Rycroft, Kwei‐Lan Tsao, Angela Williams, Christopher J. Swain	50
7	Synthesis and sar of 2- and 3-substituted 7-azaindoles as potential dopamine D4 ligands 1999 ·Bioorganic & Medicinal Chemistry Letters ·Neil R. Curtis, Janusz J. Kulagowski, Paul D. Leeson, Mark P. Ridgill, Frances Emms, Stephen B. Freedman, Shil Patel, Smita S. Patel	40
8	4-Heterocyclyl tetrahydropyridines as selective ligands for the human dopamine D4 receptor 1997 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Timothy Harrison, Janusz J. Kulagowski, Paul D. Leeson, Andrew P. Owens, Mark P. Ridgill, Martin Teall, Mark R. Fielding, Kerry L. Chapman, Frances Emms, R. Marwood, Shil Patel, (unknown)	2
9	L-745,870, a Subtype Selective Dopamine D4 Receptor Antagonist, Does Not Exhibit a Neuroleptic-Like Profile in Rodent Behavioral Tests 1997 ·Journal of Pharmacology and Experimental Therapeutics ·Linda J. Bristow, Neil Collinson, (unknown), Neil R. Curtis, Ben Freedman, Janusz J. Kulagowski, Paul D. Leeson, (unknown), C I Ragan, Mark P. Ridgill, Kay L. Saywell, Mark D. Tricklebank	82
10	3-[[4-(4-Chlorophenyl)piperazin-1-yl]methyl]-1H-pyrrolo[2,3-b]pyridine: An Antagonist with High Affinity and Selectivity for the Human Dopamine D₄ Receptor 1996 ·Journal of Medicinal Chemistry ·Janusz J. Kulagowski, Howard B. Broughton, Neil R. Curtis, Ian M. Mawer, Mark P. Ridgill, Raymond Baker, Frances Emms, Stephen B. Freedman, Rosemarie Marwood, Shil Patel, Smita S. Patel, C I Ragan, Paul D. Leeson	228
11	Synthesis and SAR of diiodotyrosine-derived glycine-site N-methyl-D-aspartate receptor ligands 1996 ·Bioorganic & Medicinal Chemistry Letters ·Neil R. Curtis, Janusz J. Kulagowski, Paul D. Leeson, Ian M. Mawer, Mark P. Ridgill, Michael Rowley, Sarah Grimwood, George Marshall	5
12	ChemInform Abstract: 3′‐(Arylmethyl)‐ and 3′‐(Aryloxy)‐3‐phenyl‐4‐hydroxyquinolin‐2(1H)‐ ones: Orally Active Antagonists of the Glycine Site on the NMDA Receptor. 1994 ·ChemInform ·Janusz J. Kulagowski, R. Baker, Neil R. Curtis, Paul D. Leeson, Ian M. Mawer, Angela M. Moseley, Mark P. Ridgill, Michael Rowley, Ian Stansfield, Alan C. Foster, S. Grimwood, Reginald Hill, J A Kemp, Garland R. Marshall, Kay L. Saywell, Mark D. Tricklebank	11
13	Amino acid bioisosteres: design of 2-quinolone derivatives as glycine-site N-methyl-D-aspartate receptor antagonists 1993 ·Bioorganic & Medicinal Chemistry Letters ·Paul D. Leeson, Raymond Baker, Robert W. Carling, Janusz J. Kulagowski, Ian M. Mawer, Mark P. Ridgill, Michael Rowley, Julian D. Smith, Ian Stansfield, Graeme I. Stevenson, Alan C. Foster, John A. Kemp	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact